In obesity treatment, two options stand out: the swallowable gastric balloon and GLP-1 receptor agonists (GLP-1 RA). Which one is right for you? In this article, we offer an unbiased comparison based on clinical data.
Disclaimer: This content is for informational purposes only. Only a physician can decide which treatment is right for you.
Quick Comparison
| Swallowable Gastric Balloon | GLP-1 Receptor Agonists | |
|---|---|---|
| Application | One-time, 20 min | Daily/weekly injection |
| Duration | 16 weeks | Continuous use |
| Average weight loss (TBWL) | 13–16%¹ | 12–18%² (depending on the drug) |
| Weight regain risk | Depends on a good program | High when the drug is stopped³ |
| Surgery/endoscopy | None | None |
| Long-term sustainability | Program-dependent | Drug-dependent |
| FDA approval (obesity) | Yes (2026, PMA Class III) | Yes (some) |
Efficacy: What Do the Numbers Say?
Gastric Balloon
In the 2020 multicenter study (n=1,770), a mean 14.9% TBWL was achieved with the Allurion balloon¹. A comprehensive 2026 analysis (n=2,454) shared results comparing different balloon systems².
GLP-1 Receptor Agonists
GLP-1 RAs can provide effective weight loss. However, an important point: weight regain is common when the drug is stopped. A meta-analysis covering 18 RCTs (n=3,771) shows that discontinuation of GLP-1 RAs leads to an average of +5.63 kg of weight regain³.
¹ PMID: 32279182 — Ienca et al., Obesity Surgery, 2020 ² PMID: 41705686 — Bastid et al., 2026 ³ PMID: 41399474 — Meta-analysis, EClinicalMedicine, 2025
Factors That Make a Difference
1. Sustainability
For GLP-1 RA treatment to be sustained, drug use must continue. The gastric balloon, on the other hand, reinforces lifestyle change by providing a 16-week "kickstart momentum."
2. Side Effects
Gastrointestinal side effects such as diarrhea, nausea, and vomiting can occur with both approaches. The profile differs, but the intensity is similar.
3. What Is Suitable for Whom?
- BMI 27–35, doesn't want to take medication: Balloon comes to the fore
- BMI 35+, metabolic problems: Both options are evaluated
- Ready for long-term drug use: GLP-1 RA may be considered
- Barrier: fear of needles or burden of daily injections: Balloon is advantageous
Combined Approach: The Two Together?
In a study published in 2025, the combination of an intragastric balloon with GLP-1 RA was reported to show a synergistic effect (PMID: 41212463). This approach is not yet a standard protocol; however, it has become a focus of research.
Allurion also clarified the interest in this area by announcing a collaboration with Eli Lilly (February 2026).
Conclusion
Both treatments are effective; however, they address different needs. Looking at the weight regain data, it appears that the gastric balloon + lifestyle program may offer an advantage in terms of long-term sustainability.
The right decision is made after an individual assessment with a specialist.
Find an Authorized Clinic in a City Near You
You can have the Allurion Program performed at more than 60 authorized clinics across Türkiye. For clinics in major cities:
Clinical Sources
Related Articles
Weight Loss Injection Side Effects and Alternatives: A Balanced 2026 Guide
Weight loss injection (GLP-1) side effects, 2026 prices, and alternatives: real data, weight regain risk after stopping, and the swallowable gastric balloon option.
Gastric Balloon + GLP-1 Combination Therapy: Efficacy and Protocol
A new-generation protocol combining the gastric balloon with GLP-1 receptor agonists: mechanism, preliminary clinical data, advantages, and patient guidance.
What Happens When You Stop Ozempic and GLP-1? Weight Regain Data
Do you regain weight after stopping GLP-1 drugs like Ozempic, Wegovy, and Mounjaro? The data, based on an 18-RCT meta-analysis and a BMJ 2026 review.
Related Pages
Which method is right for you?
Let our specialist physicians evaluate you free of charge.
Free Pre-Assessment →